The majority of DLBCL patients treated with aCD20 + CT expressed neither IgG or IFN-γ (Fig. 1B, Fig. 3B, Extended Fig. 1C, and Fig. 3C). This evidence concerns the gene IFNG and diffuse large B-cell lymphoma.